Page History

• Not clear if we really can have a successful collaboration, however we have let them know if they can find a way to work with us that the ICDC would be interested.
• Their public data is a candidate for the ICDC
• They are interested in correlating data with biomarkers and that is an area of interest for the ICDC
• Work instead with peer reviewed and published scientists that use FidoCure data
• Their data may not be useful to predict outcomes

New ICDC Working Group: Longitudinal Data Acquisition and Use Working Group (LDAUWG)

Purpose: Formulate scientific questions and use cases that can be used to interrogate longitudinal datasets that would justify the ingestion of such data into the ICDC.

• New ICDC  1-pager
• First meeting is scheduled for Friday March 1st

ICDC Studies in Active Submission

• COTC021
  
  • "Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
  • Dr. Amy LeBlanc
  • Status: Files have been transferred, but they are not in the requested format
• UBC03
  • "Transcriptomic analyses of early stage bladder cancer in Scottish Terriers detected through screening"
  • Dr. Debbie Knapp
  • Status: Metadata transfer is in progress
• OSA02
  • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
    
  • Dr. Dawn Duval
  • Status: Files and metadata have been received and are in review

• Collect biospecimen data so that we can build a page in the ICDC application
• ICDC Biospecimen Data

• February April meeting: Tuesday February 20thMonday April 15th
• The minutes can be reviewed in the meeting invite